论文部分内容阅读
目的:观察雷贝拉唑联合莫沙必利抗反流治疗对支气管哮喘合并GERD患者哮喘的疗效。方法:将30例合并GERD的哮喘患者分为两组,治疗组在常规哮喘药物治疗的同时加用雷贝拉唑20mg每日1次及莫沙必利5mg每日3次共8周。结果:经抗反流治疗8周后,哮喘控制有效率差异有统计学意义(P<0.05)。结论:对合并GERD的哮喘患者进行抗反流治疗,可改善哮喘症状。
Objective: To observe the curative effect of rabeprazole and mosapride anti-reflux therapy on bronchial asthma patients with asthma combined with GERD. Methods: Thirty patients with asthma with GERD were divided into two groups. The treatment group was treated with rabeprazole 20 mg once daily and mosapride 5 mg three times daily for 8 weeks in addition to the conventional asthma medication. Results: After 8 weeks of anti-reflux treatment, the effective rate of asthma control was statistically significant (P <0.05). Conclusion: Anti-reflux treatment of asthmatic patients with GERD may improve asthma symptoms.